01 1 Radicut
02 8Radicava
03 3Radicut
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 201
2019 Revenue in Millions : 218
Growth (%) : -8
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 210
2020 Revenue in Millions : 198
Growth (%) : 14
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 349
2021 Revenue in Millions : 208
Growth (%) : 68
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 483
2022 Revenue in Millions : 349
Growth (%) : 55
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 28
2022 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 605
2023 Revenue in Millions : 542
Growth (%) : 12
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 41
2023 Revenue in Millions : 48
Growth (%) : -16
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 54
2016 Revenue in Millions : 60
Growth (%) : -10
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : -32%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 61
2016 Revenue in Millions : 0
Growth (%) : New Launch
